hims & hers peptide regulation - Stock Newsroom

S TOCK newsroom .COM

S&P 500 7,134 +1.25%

DJIA 49,504 +1.76%

Nasdaq 26,705 +1.46%

DAX 24,649 +2.17%

Gold $4,196 +0.16%

Oil $83.46 -6.92%

BTC $77,326 +2.81%

VIX 20.33 -0.60%

EUR/USD 1.1785 -0.02%

ETH $2,426 +3.30%

S&P 500 7,134 +1.25%

DJIA 49,504 +1.76%

Nasdaq 26,705 +1.46%

DAX 24,649 +2.17%

Gold $4,196 +0.16%

Oil $83.46 -6.92%

BTC $77,326 +2.81%

VIX 20.33 -0.60%

EUR/USD 1.1785 -0.02%

ETH $2,426 +3.30%

hims & hers peptide regulation

Surging stock chart in biotech setting reflecting Hims & Hers peptide regulation rally

Pharma & Healthcare·Stocks·USA

Hims & Hers peptide regulation: +10.5% rally tests FDA bet

By Maik Kemper • Apr 16, 2026

Surging stock chart in biotech setting reflecting Hims & Hers peptide regulation rally

Pharma & Healthcare·Stocks·USA

Hims & Hers peptide regulation: +10.5% rally tests FDA bet

By Maik Kemper • Apr 16, 2026

Is the latest FDA shift on peptides turning Hims & Hers into a long-term growth story or just fueling a speculative spike? Maik Kemper Editor…